Radiation and chemotherapy for high‐risk lower grade gliomas: Choosing between temozolomide and PCV-Reference-Cited by-同舟云学术

Radiation and chemotherapy for high‐risk lower grade gliomas: Choosing between temozolomide and PCV

Published:2019-11-07 Issue:1 Volume:9 Page:3-11
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

McDuff Susan G. R.¹^ORCID,Dietrich Jorg²,Atkins Katelyn M.³,Oh Kevin S.⁴,Loeffler Jay S.⁴,Shih Helen A.⁴^ORCID

Affiliation:

1. Department of Radiation Oncology Duke Cancer Center, Medicine Circle Durham NC USA

2. Department of Neurology Division of Neuro‐Oncology Massachusetts General Hospital Boston MA USA

3. Department of Radiation Oncology Cedars‐Sinai Medical Center Los Angeles CA USA

4. Department of Radiation Oncology Massachusetts General Hospital Boston MA USA

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2686

Reference52 articles.

1. Low-Grade Gliomas

2. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

3. Tailored therapy in diffuse gliomas: using molecular classifiers to optimize clinical management. | Harvard Catalyst Profiles | Harvard Catalyst;Taylor JW;Oncology,2013

4. Isocitrate dehydrogenase-mutant glioma: Evolving clinical and therapeutic implications

5. Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bibliometric Analysis to Improve Combined Treatment Strategies for Glioblastoma in America;Current Cancer Therapy Reviews;2024-11

2. T2-FLAIR imaging-based radiomic features for predicting early postoperative recurrence of grade II gliomas;Future Oncology;2024-09-13

3. Transcriptomic analysis identifies the neuropeptide cortistatin (CORT) as an inhibitor of temozolomide (TMZ) resistance by suppressing the NF-κB-MGMT signaling axis in human glioma;Genes & Diseases;2024-05

4. New melphalan derivatives for the treatment of retinoblastoma in combination with thermotherapy;RSC Medicinal Chemistry;2024

5. A gene signature predicting prognosis of patients with lower-grade gliomas receiving temozolomide therapy;Discover Oncology;2023-11-13